Published in J Mol Cell Cardiol on November 04, 2011
G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol (2013) 0.92
Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties. J Biol Chem (2016) 0.80
Endothelial Restoration of Receptor Activity-Modifying Protein 2 Is Sufficient to Rescue Lethality, but Survivors Develop Dilated Cardiomyopathy. Hypertension (2016) 0.77
Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med (2015) 0.77
Cohort of estrogen-induced microRNAs regulate adrenomedullin expression. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats. PLoS One (2016) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (1998) 5.98
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest (2008) 2.31
Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem (2002) 2.14
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol (1999) 1.89
GPCR modulation by RAMPs. Pharmacol Ther (2005) 1.85
17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res (2004) 1.74
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther (2006) 1.44
Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol (2004) 1.41
Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation (2007) 1.39
Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci (2005) 1.39
Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol (2006) 1.35
Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol (2007) 1.28
Gender-specific regulation of cardiovascular function: estrogen as key player. Microcirculation (2004) 1.25
Global uterine genomics in vivo: microarray evaluation of the estrogen receptor alpha-growth factor cross-talk mechanism. Mol Endocrinol (2004) 1.24
Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens (2011) 1.24
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc Natl Acad Sci U S A (2004) 1.21
Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol (2006) 1.19
Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation (2003) 1.18
Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem (2007) 1.18
A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A (2002) 1.15
Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation (2000) 1.12
Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol (2008) 1.12
Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J (2006) 1.10
Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking. J Biol Chem (2004) 1.09
Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol (2006) 1.08
Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2003) 1.05
RAMPs: 5 years on, where to now? Trends Pharmacol Sci (2003) 1.04
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail (2010) 1.02
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail (2009) 0.99
The estrogen-responsive adrenomedullin and receptor-modifying protein 3 gene identified by DNA microarray analysis are directly regulated by estrogen receptor. J Mol Endocrinol (2006) 0.98
Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry (2009) 0.97
Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension (2003) 0.95
Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun (2000) 0.95
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males. Proc Natl Acad Sci U S A (2007) 0.92
Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1. J Biol Chem (2005) 0.92
Akt signaling pathway in pacing-induced heart failure. Mol Cell Biochem (2005) 0.92
Lifelong genetic minipumps. Physiol Genomics (2004) 0.92
Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function. Mol Cell Endocrinol (2000) 0.91
Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun (2000) 0.89
Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. J Pharmacol Exp Ther (2005) 0.89
Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr Med Chem Cardiovasc Hematol Agents (2005) 0.88
Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen. Herz (2005) 0.87
Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun (2002) 0.86
Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides (2007) 0.85
Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension. Am J Hypertens (2009) 0.84
mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am J Physiol Lung Cell Mol Physiol (2001) 0.83
Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells. Biochem Pharmacol (2003) 0.82
An improved technique for tail-cuff blood pressure measurements with dark-tailed mice. Contemp Top Lab Anim Sci (2005) 0.81
Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinology (2002) 0.81
Mechanism of cardioprotection: what can we learn from females? Pediatr Cardiol (2011) 0.80
Receptor activity modifying proteins and their potential as drug targets. Prog Mol Biol Transl Sci (2010) 0.80
Physiological significance and therapeutic potential of adrenomedullin in pulmonary hypertension. Cardiovasc Hematol Disord Drug Targets (2006) 0.79
Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat. Basic Res Cardiol (2006) 0.78
Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension. Regul Pept (2003) 0.78
Novel regulation of adrenomedullin receptor by PDGF: role of receptor activity modifying protein-3. Am J Physiol Cell Physiol (2002) 0.78
RAMP2 and RAMP3 mRNA levels are increased in failing rat cardiomyocytes and associated with increased responsiveness to adrenomedullin. J Mol Cell Cardiol (2004) 0.78
Ventricular adrenomedullin system in the transition from LVH to heart failure in rats. Hypertension (2003) 0.77
Adrenomedullin infusion during ischemia/reperfusion attenuates left ventricular remodeling and myocardial fibrosis in rats. Hypertens Res (2003) 0.77
Functional characterization of two human receptor activity-modifying protein 3 variants. Peptides (2009) 0.77
Upregulation of intracardiac adrenomedullin and its receptor system in rats with volume overload-induced cardiac hypertrophy. Regul Pept (2005) 0.76
Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest (2008) 2.31
Cyclooxygenase-2 regulates Th17 cell differentiation during allergic lung inflammation. Am J Respir Crit Care Med (2011) 2.15
Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol (2006) 1.35
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest (2006) 1.22
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem (2007) 1.22
Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol (2006) 1.19
Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth. J Pharmacol Exp Ther (2010) 1.09
Haploinsufficiency for adrenomedullin reduces pinopodes and diminishes uterine receptivity in mice. Biol Reprod (2008) 1.04
Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population. Pharmacogenet Genomics (2010) 1.04
Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice. PLoS One (2012) 1.01
RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest (2015) 0.99
Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta. J Clin Invest (2013) 0.99
Adrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo. Peptides (2008) 0.95
Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models. Curr Hypertens Rev (2011) 0.95
Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury. J Lipid Res (2012) 0.94
Adrenomedullin and pregnancy: perspectives from animal models to humans. Trends Endocrinol Metab (2012) 0.94
G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol (2013) 0.92
Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice. Endocrinology (2013) 0.90
The influence of fitness and body weight on preferred exercise intensity. Med Sci Sports Exerc (2006) 0.90
Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol (2011) 0.89
Uterine natural killer cells as modulators of the maternal-fetal vasculature. Int J Dev Biol (2014) 0.89
Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes. Am J Respir Cell Mol Biol (2013) 0.88
Epicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis. Dev Dyn (2014) 0.88
The epoxyeicosatrienoic acid-stimulated phosphorylation of EGF-R involves the activation of metalloproteinases and the release of HB-EGF in cancer cells. Acta Pharmacol Sin (2010) 0.87
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. Am J Respir Cell Mol Biol (2010) 0.87
Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles. Genetics (2009) 0.86
Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis. FASEB J (2012) 0.86
G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arterioscler Thromb Vasc Biol (2009) 0.85
Schlemm's canal: more than meets the eye, lymphatics in disguise. J Clin Invest (2014) 0.83
Understanding RAMPs through genetically engineered mouse models. Adv Exp Med Biol (2012) 0.82
Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB. Am J Respir Crit Care Med (2013) 0.82
Cigarette smoke-induced placental adrenomedullin expression and trophoblast cell invasion. Reprod Sci (2013) 0.81
Effect of exercise intensity on differentiated and undifferentiated ratings of perceived exertion during cycle and treadmill exercise in recreationally active and trained women. J Sports Sci Med (2010) 0.80
Adrenomedullin in lymphangiogenesis: from development to disease. Cell Mol Life Sci (2015) 0.75
Apelin signaling: new G protein-coupled receptor pathway in lymphatic vascular development. Arterioscler Thromb Vasc Biol (2014) 0.75
Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest (2017) 0.75